The polyphosphoinositide PtdIns(4,5)P # , best known as a substrate for phospholipase C isozymes, has recently been recognized to be involved in a variety of other cellular processes. The aim of this study was to examine whether the cellular levels of this versatile phospholipid are controlled by tyrosine phosphorylation. The studies were performed in human embryonic kidney (HEK)-293 cells stably expressing the M $ muscarinic acetylcholine receptor. Inhibition of tyrosine phosphatases by pervanadate induced an up-to-approx.-2.5-fold increase in the total cellular level of PtdIns(4,5)P # , which was both time-and concentration-dependent. In contrast, the tyrosine kinase inhibitors, genistein and tyrphostin 23, caused a rapid and specific fall in the cellular PtdIns(4,5)P # level and prevented the stimulatory effect of pervanadate on PtdIns(4,5)P # formation. Inactivation of Rho proteins by Clostridium difficile toxin B caused a similar fall in
INTRODUCTION
Altered metabolism of phosphoinositides, specifically of PtdIns(4,5)P # , plays an essential role in various cellular processes. This polyphosphoinositide serves as a substrate for phosphoinositide-specific phospholipase C enzymes, generating the second messengers Ins(1,4,5)P $ and diacylgycerol [1, 2] . In addition, PtdIns(4,5)P # can be converted by PtdIns-3-kinases to PtdIns(3,4,5)P $ , which is apparently involved in cellular signalling of various growth factor receptors [3] . Furthermore, PtdIns(4,5)P # has been shown to both bind to and regulate the activity of numerous proteins, including various actin-binding proteins, many pleckstrin-homology-domain-containing proteins and even ion channels [4] [5] [6] [7] [8] [9] . The major pathway of PtdIns(4,5)P # synthesis is apparently mediated by type I PtdIns4P 5-kinases, three isoforms of which have recently been cloned [10] [11] [12] . The numerous cellular functions attributed to PtdIns(4,5)P # suggest strongly that the level of this phospholipid is tightly controlled.
Phospholipase D (PLD) enzymes, which hydrolyse phosphatidylcholine into phosphatidic acid and choline, have recently been recognized to belong with the many enzymes whose activity is regulated by PtdIns(4,5)P # . While PtdIns(4,5)P # is, thus far, the only known regulator of PLD2 enzymes, PLD1 enzymes are regulated additionally by ADP-ribosylation factor (ARF) and Rho proteins, two low-molecular-mass GTPases [13] [14] [15] [16] . Both ARF and Rho proteins not only stimulate PLD, but can apparently also increase PtdIns(4,5)P # synthesis by PtdInsP 5-kinases, although a direct stimulation of these kinases has not Abbreviations used : ARF, ADP-ribosylation factor ; HBSS, Hank's balanced salt solution ; HEK, human embryonic kidney ; mAChR, muscarinic acetylcholine receptor ; PLD, phospholipase D ; PtdEtOH, phosphatidylethanol. 1 To whom correspondence should be addressed (e-mail ulrich.ruemenapp!uni-essen.de).
the HEK-293 cell PtdIns(4,5)P # level, which was not altered by additional genistein treatment. Furthermore, toxin B treatment abolished the pervanadate-induced increase in PtdIns(4,5)P # levels. As PtdIns(4,5)P # is an essential stimulatory cofactor for phospholipase D (PLD) enzymes, we finally examined the effects of the agents regulating PtdIns(4,5)P # levels on PLD activity in HEK-293 cells. Inhibition of tyrosine phosphatases by pervanadate caused an increase in PLD activity, which was susceptible to genistein and tyrphostin 23, and which was abolished by prior treatment with toxin B. In conclusion, the data presented indicate that the cellular level of the multifunctional phospholipid, PtdIns(4,5)P # , in HEK-293 cells is controlled by a tyrosinekinase-dependent mechanism and that this process apparently involves Rho proteins, as found similarly for tyrosinephosphorylation-induced PLD activation.
been reported so far [17] [18] [19] [20] [21] . Rather, the PLD product, phosphatidic acid, is the best known activator of type I PtdInsP 5-kinases [10] [11] [12] .
Receptor regulation of PLD activity in human embryonic kidney (HEK)-293 cells, stably expressing the human M $ muscarinic acetylcholine receptor (mAChR) subtype, involves both ARF and Rho proteins [22, 23] . Studies on the mechanisms of PLD inhibition by Clostridium difficile toxin B and C. botulinum C3 exoenzyme, which inactivate Rho family GTPases [24] , indicated that these toxins decrease the cellular level of PtdIns(4,5)P # [25, 26] . As receptor stimulation of PLD activity in HEK-293 cells additionally involves a tyrosine-kinase-dependent mechanism [27] , as reported similarly for other cell types [28, 29] , we have examined in this study whether the cellular level of PtdIns(4,5)P # is under the control of tyrosine phosphorylation. We report here that a tyrosine-kinase-dependent mechanism, apparently involving Rho proteins, regulates the synthesis of PtdIns(4,5)P # in HEK-293 cells. were obtained from Biomol (Hamburg, Germany). C. difficile toxin B was purified as described previously [30] . Pervanadate (10 mM stock solution) was produced from a combination of 20 mM H # O # and 20 mM orthovanadate, and allowed to stand at room temperature for at least 15 min. All other materials were from sources described previously [22, 26, 27] .
MATERIALS AND METHODS

Materials
Cell culture
Culture conditions of HEK-293 cells, stably expressing the M $ mAChR, were set up as described previously [27] . For these experiments, cells subcultured in Dulbecco's modified Eagle's medium\F-12 medium were grown to near-confluency (in 175-cm# culture flasks or 35-and 145-mm culture dishes).
Phosphoinositide analysis
HEK-293 cell phosphoinositide levels were determined as described previously [25, 26] . Briefly, phosphoinositides were labelled by incubating nearly confluent monolayers of cells for 20-24 h with [$H]inositol (0.5-1 µCi\ml) in inositol-free growth medium. In studies on the effects of toxin B on phosphoinositide levels, the labelling medium was then replaced by normal growth medium, followed by treatment of the cells for 24 h with or without toxin B at the indicated concentrations. Thereafter, cells were detached from the culture flasks, washed once in PBS containing 137 mM NaCl, 2.7 mM KCl, 0.9 mM CaCl # , 0. 
Assay of PLD activity
PLD activity was determined as described previously [27] . Briefly, cellular phospholipids were labelled by incubating nearly confluent monolayers of cells for 20-24 h with [$H]oleic acid (2-2.5 µCi\ml) in growth medium. Thereafter, the cells were detached from the culture flasks, washed once in PBS and finally resuspended in HBSS. Accumulation of the specific PLD product, [$H]phosphatidylethanol ([$H]PtdEtOH), was then measured in the presence of ethanol (1.75 %, v\v) for the indicated periods of time at 37 mC in a total vol. of 200 µl, containing 100 µl of the cell suspension (1i10' cells). Termination of the reactions and isolation of radiolabelled phospholipids were performed as described previously [27] . Formation of [$H]PtdEtOH is expressed as the percentage of total counts in the phospholipid fraction.
Assay of ARF translocation
Translocation of ARF proteins was monitored as described previously [22] . Briefly, HEK-293 cells were detached from culture flasks, washed once with PBS and resuspended in PBS at a density of about 2i10' cells\ml. After 10 min incubation at 37 mC in the absence or presence of 1 mM carbachol, cells were pelleted and resuspended in 500 µl of buffer A [135 mM KCl\5 mM NaHCO $ \5 mM EGTA\5.6 mM -glucose\2 mM ATP\4 mM MgCl # \1.5 mM CaCl # \20 mM Hepes (pH 7.2)] without or with 8 µM digitonin, and incubated for 15 min at 37 mC. Thereafter, cells were pelleted by high-speed centrifugation, and proteins in the supernatant fraction were analysed for ARF protein content with a polyclonal anti-(recombinant ARF1) antibody.
Assay of tyrosine phosphorylation
HEK-293 cells were detached from culture flasks, washed once with PBS and resuspended in HBSS. Approx. 1i10' cells were preincubated for 15 min at 37 mC in the absence or presence of 100 µM genistein or tyrphostin 23, followed by incubation for 2 min in the absence or presence of 1 mM pervanadate (total vol. of 60 µl). The reaction was stopped by adding 30 µl of lysis buffer, containing 6 % (w\v) SDS, 18 % (w\v) 2-mercaptoethanol, 30 % (v\v) glycerol, 1 mM Na $ VO % and a trace amount of Bromophenol Blue dye in 200 mM Tris\HCl, pH 7.5, followed by heating for 5 min at 95 mC. SDS\PAGE, transfer of proteins to nitrocellulose filters and detection of phosphotyrosine-containing proteins using anti-phosphotyrosine antibodies and the enhanced chemiluminescence Western blotting detection system (Amersham) have been described previously [27] .
RESULTS
Regulation of HEK-293 cell PtdIns(4,5)P 2 levels by tyrosine phosphorylation
To study a tyrosine-phosphorylation-dependent regulation of phosphoinositide levels in HEK-293 cells, we examined the effects of the protein tyrosine phosphatase inhibitor, pervanadate [31] , and the tyrosine kinase inhibitors, genistein and tyrphostin 23, on the total cellular levels of PtdIns, PtdIns4P and PtdIns(4,5)P # . To meet this aim, HEK-293 cells prelabelled with [$H]inositol were treated with the above-mentioned agents, followed by extraction and quantification of the labelled phosphoinositide species. As shown in Table 1 neither orthovanadate nor H # O # (at 1 mM each), from which the pervanadate was generated, altered the level of any of the phosphoinositides. The stimulatory effect of pervanadate on the [$H]PtdIns(4,5)P # level was half-maximal at about 100 µM, and a maximal increase was observed at 1 mM pervanadate ( Figure  1A ). The time course of pervanadate-induced [$H]PtdIns(4,5)P # accumulation (at 1 mM) was almost linear for the first 30 min, with no major changes occurring at later time points ( Figure 1B) .
The stimulatory effect of pervanadate on the level of PtdIns(4,5)P # was apparently due to inhibition of tyrosine phosphatases, as determined with the tyrosine kinase inhibitors, genistein and tyrphostin 23. Pretreatment of HEK-293 cells for 15 min with either genistein or tyrphostin 23 (100 µM each) almost completely prevented the increase in PtdIns(4,5)P # level induced by pervanadate, both at its half-maximally and maximally effective concentrations ( Table 2 ). The tyrosine kinase inhibitors did not only prevent the stimulatory effect of pervanadate, but also caused, by themselves, a significant reduction in the level of PtdIns (4,5 Pervanadate and the tyrosine kinase inhibitors exhibited the expected effects on protein tyrosine phosphorylation. As shown in Figure 3 , treatment of HEK-293 cells with pervanadate (1 mM) strongly increased the tyrosine phosphorylation of a large number of proteins. The stimulatory effect of pervanadate was inhibited strongly by prior treatment with tyrphostin 23 (100 µM), which also lowered the tyrosine phosphorylation of several proteins in cells not treated with pervanadate. Similar effects were observed with genistein (results not shown).
Role of Rho proteins in tyrosine-phosphorylation-dependent PtdIns(4,5)P 2 synthesis
Since PtdIns(4,5)P # synthesis in HEK-293 cells is apparently controlled by both tyrosine phosphorylation and Rho proteins [25, 26] , the relationship between these two regulatory mechanisms was examined. Therefore we studied the effects of Rho protein inactivation by C. difficile toxin B on both the genisteininduced fall and the pervanadate-induced rise in phosphoinositide levels. Hence, HEK-293 cells prelabelled with [$H]-inositol were first treated for 24 h with or without toxin B, followed by a second incubation for 60 min with or without genistein or pervanadate. As shown in Figure 4 increased in both control and toxin-B-treated cells similarly, by about 50 % (Table 3 ). In contrast, the rise in [$H]PtdIns(4,5)P # level ( 2-fold) caused by pervanadate in control cells was completely absent in cells pretreated with toxin B, the data for which suggest that the tyrosine-phosphorylation-dependent increase in PtdIns(4,5)P # levels is mediated by Rho proteins. As found in other cell types, ARF proteins have been implicated in the control of PtdIns(4,5)P # synthesis [17, 18] . We therefore examined whether the activity state of these proteins in HEK-293 cells is controlled by tyrosine phosphorylation. Activation of either ARF or Rho proteins is associated with a translocation of the proteins from the cytosol to the membranes. We have recently reported that M $ mAChR activation induces translocation of ARF and RhoA proteins from the cytosol to the membranes in HEK-293 cells [22, 32] . Furthermore, the mAChRinduced RhoA translocation was prevented by genistein and tyrphostin 23, and mimicked by pervanadate [32] . Similar experiments performed on the subcellular distribution of ARF proteins showed that treatment of HEK-293 cells with pervanadate (1 mM, 30 min) did not affect the cytosol-membrane distribution of ARF proteins (results not shown). Moreover, as shown in Figure 5 , pretreatment of HEK-293 cells for 30 min with genistein (100 µM) did not decrease basal or carbachol-induced reductions in cytosolic ARF content, measured as immunoreactive ARF proteins (19 kDa) released from digitonin-permeabilized cells. Thus in contrast with RhoA activation, ARF activation in HEK-293 cells is apparently not controlled by a tyrosine-phosphorylation-dependent process.
Regulation of PLD activity by tyrosine phosphorylation
In common with other PLD enzymes, HEK-293 cell PLD activity is stimulated by PtdIns(4,5)P # [26] . Therefore we examined the effects of the agents regulating PtdIns(4,5)P # levels under very similar conditions on PLD activity in HEK-293 cells. First, as reported previously [27] with HEK-293 cell monolayers, the tyrosine phosphatase inhibitor, pervanadate, increased PLD activity in HEK-293 cell suspensions ( Figure 6A) . The maximal (Table 4) , indicating the involvement of tyrosine phosphorylation in pervanadate's action on PLD activity. Thirdly, the effect of inactivation of Rho protein by toxin B on PLD stimulation by pervanadate was examined. As shown in Table 4 , pretreatment of HEK-293 cells with toxin B (2 ng\ml, 24 h) completely prevented the stimulatory effect of pervanadate (1 mM) on PLD activity. 
DISCUSSION
Regulation of PLD activity involves various signalling molecules, including the two low-molecular-mass GTPases, ARF and Rho, and the phosphoinositide, PtdIns(4,5)P # [16] . In addition, as demonstrated here for HEK-293 cells stably expressing the M $ mAChR, an as-yet-unidentified tyrosine kinase is apparently involved in PLD stimulation. First, treatment of HEK-293 cells with the phosphotyrosine phosphatase inhibitor, pervanadate, which induced accumulation of several tyrosine-phosphorylated proteins, increased markedly PLD activity. Secondly, PLD stimulation by pervanadate was prevented by the tyrosine kinase inhibitors, genistein and tyrphostin 23. Thirdly, these inhibitors also prevented PLD stimulation caused by mAChR activation or by direct activation of heterotrimeric G-proteins [27] , indicating that the putative tyrosine kinase plays a essential role in receptor signalling to PLD.
In studies on the mechanisms of PLD inhibition by C. difficile toxin B and C. botulinum C3 exoenzyme in HEK-293 cells, we observed that these Rho-protein-inactivating toxins decrease the cellular level of PtdIns(4,5)P # [25, 26] . Therefore we examined in this study whether the level of PtdIns(4,5)P # in HEK-293 cells is regulated by a tyrosine-phosphorylation-dependent mechanism. In addition, we studied whether Rho and\or ARF proteins are involved in this process, since both GTPases have been reported to stimulate PtdIns(4,5)P # synthesis [17] [18] [19] [20] [21] . We demonstrate here that the level of PtdIns(4,5)P # in HEK-293 cells is controlled by a tyrosine-kinase-dependent mechanism, and that this process apparently involves Rho proteins. First, treatment of HEK-293 cells with the two structurally distinct tyrosine kinase inhibitors, genistein and tyrphostin 23, caused both a specific and rapid reduction, by about 50 %, in the cellular level of PtdIns(4,5)P # , without altering the levels of PtdIns and PtdIns4P, as reported similarly before for toxin B and C3 exoenzyme [25, 26] . Comparable with our observations in HEK-293 cells, genistein has been reported to decrease the level of PtdIns(4,5)P # in human platelets [33] and rat pancreatic acini [34] , although slightly increasing that of PtdIns4P. Secondly, genistein did not synergize with toxin B in reducing the level of PtdIns(4,5)P # in HEK-293 cells, suggesting that the genistein-sensitive tyrosine kinase and Rho proteins regulate the same pool of PtdIns(4,5)P # in concert and do not act independently of each other. Thirdly, treatment of HEK-293 cells with the phosphotyrosine phosphatase inhibitor, pervanadate, but not with orthovanadate or H # O # , markedly increased the level of PtdIns(4,5)P # by about 2.5-fold, whereas that of PtdIns4P was increased by only about 50 %, with no change in the level of PtdIns. The observation that even relatively large changes in the level of PtdIns(4,5)P # , i.e. a 2.5-fold increase in response to pervanadate, did not lead to significant changes in the levels of PtdIns and PtdIns4P is best explained by the fact that the level of PtdIns is 20-30 times higher than that of PtdIns(4,5)P # , and that in intact cells the depleted PtdIns4P is rapidly replenished by PtdIns kinases. Fourthly, the pervanadateinduced increase in PtdIns(4,5)P # levels was prevented by genistein and tyrphostin 23, indicating that the effect of pervanadate is indeed due to inhibition of tyrosine phosphatases. Finally, inactivation of Rho proteins by toxin B treatment of HEK-293 cells, which did not affect the rather small increase in PtdIns4P, eliminated completely the pervanadate-induced elevation in PtdIns(4,5)P # level. Direct inhibition (by genistein and tyrphostin 23) and activation (by pervanadate) of PtdIns4P 5-kinases are unlikely to cause the observed changes in PtdIns(4,5)P # level for the following reasons. First, it would be highly fortuitous if the same agents inhibiting or increasing tyrosine phosphorylation had the same effects on PtdIns4P 5-kinase activities. Secondly, genistein decreased the PtdIns(4,5)P # level to a similar extent as toxin B, but in a non-additive manner ; thus if genistein does directly inhibit PtdIns4P 5-kinase, it would be expected that this direct inhibition would be additive to the (indirect) inhibitory effect of toxin B. Finally, the stimulatory effect of pervanadate on PtdIns(4,5)P # level was not only inhibited by genistein and tyrphostin 23, but also by toxin B, which specifically inactivates Rho proteins [23] .
All of these data suggest that synthesis of PtdIns(4,5)P # in HEK-293 cells is stimulated by a tyrosine-phosphorylationdependent mechanism, and that Rho proteins act downstream of the putative tyrosine kinase. A similar concept of a signalling cascade involving a tyrosine kinase upstream of Rho proteins has also been proposed for the regulation of actin polymerization and stress fibre formation in Swiss 3T3 fibroblasts by lysophosphatidic acid [35, 36] . On the other hand, we have found no evidence that ARF proteins, which have been reported to stimulate PtdIns(4,5)P # synthesis in other cell types [17, 18] , are involved in tyrosine-kinase-mediated PtdIns(4,5)P # synthesis in HEK-293 cells. First, whereas pervanadate and mAChR activation induced activation of RhoA proteins [32] , activation of ARF proteins was only detected upon mAChR activation, and not with pervanadate. Secondly, genistein and tyrphostin 23 inhibited the mAChR-induced RhoA activation, whereas the receptor-induced ARF activation was not affected by these tyrosine kinase inhibitors. In agreement with these findings, we recently observed that overexpression of wild-type RhoA, but not of wild-type ARF1, constitutively active ARF1 or ARNO (a guanine-nucleotide-exchange factor for ARF proteins), increased PtdIns(4,5)P # levels in HEK-293 cells (results not shown). There was a close correlation between the observed changes in PtdIns(4,5)P # level and PLD activity. First, formation of PtdIns(4,5)P # was stimulated solely by pervanadate (produced from a combination of orthovanadate and H # O # ), but not by either of these two agents alone, as found similarly in the increase in PLD activity mediated exclusively by pervanadate. Secondly, both effects of pervanadate were blocked by genistein and tyrphostin 23. Thirdly, both the time courses and the concentration-response curves for the pervanadate-induced synthesis of PtdIns(4,5)P # and its stimulatory effect on PLD activity were rather similar. Finally, and most importantly, treatment of HEK-293 cells with the Rho-inactivating toxin B not only prevented the pervanadate-induced increase in PtdIns(4,5)P # synthesis, but also abolished the pervanadate-induced PLD stimulation, suggesting that Rho proteins mediate the stimulatory effect of tyrosine phosphorylation on PLD activity as well. In contrast with the PtdIns(4,5)P # -regulated PLD, the PtdIns(4,5)P # -hydrolysing phospholipase C was stimulated in HEK-293 cells by both orthovanadate and pervanadate (by about 2-fold), and this effect was relatively insensitive to the presence of the tyrosine kinase inhibitors (results not shown).
Despite the close correlation observed between PtdIns(4,5)P # synthesis and PLD activity, it remains to be determined whether the increased synthesis of the stimulatory PLD cofactor, PtdIns(4,5)P # , is solely responsible for the increase in PLD activity induced by pervanadate in intact HEK-293 cells. The interpretation is complicated, particularly in view of the fact that, on one hand, PtdIns(4,5)P # can stimulate PLD enzymes [13] [14] [15] [16] , and on the other hand, phosphatidic acid generated by PLD enzymes can stimulate type I PtdIns4P 5-kinases that are responsible for PtdIns(4,5)P # synthesis [10] [11] [12] . Furthermore, Bourgoin and coworkers [37] reported recently that hPLD1 in HL-60 cells is tyrosine-phosphorylated by pervanadate. Although no functional data were provided, it is possible that this tyrosine phosphorylation increases PLD activity in itself, or alters its sensitivity to stimulatory cofactors, such as Rho and PtdIns(4,5)P # . Thus although, on the basis of the toxin B data, a direct PLD stimulation is unlikely, it remains a possibility that pervanadate not only activates (Rho) and increases the level [PtdIns(4,5)P # ] of PLD cofactors, but in addition, it may sensitize PLD for these cofactors by inducing tyrosine phosphorylation of the PLD itself.
In conclusion, we have provided evidence that the synthesis of the multifunctional phospholipid, PtdIns(4,5)P # , best known as the substrate of phospholipase C isozymes but apparently also involved intimately in a variety of other cellular processes (including PLD activation), is regulated by a tyrosine-kinasedependent mechanism in HEK-293 cells, and that this process apparently involves Rho proteins, as does tyrosine-phosphorylation-induced PLD activation. Whether or not synthesis of PtdIns(4,5)P # (mediated by tyrosine phosphorylation and Rho proteins) is under active receptor control, and the identification of the tyrosine kinase acting upstream of Rho, are areas for further investigation.
